Files
2026-07-06 17:28:36 -04:00

8.8 KiB
Raw Permalink Blame History

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
type title description jurisdiction legislature session identifier citation classification subjects status primary_sponsors version_count action_count vote_count first_action last_action source source_identifier source_url source_hash vintage source_snapshot retrieved_at confidence tags
Bill Naloxone; dispensing for use in opioid overdose reversal, etc. Allows a person who is authorized by the Department of Behavioral Health and Developmental Services to train individuals on the administration of naloxone for use in opioid overdose reversal and who is acting on behalf of an organization that provides services to individuals at risk of experiencing opioid overdose or training in the administration of naloxone for overdose reversal and that has obtained a controlled substances registration from the Board of Pharmacy pursuant to § 54.1-3423 to dispense naloxone to a person who has completed a training program on the administration of naloxone for opioid overdose reversal, provided that such dispensing is (i) pursuant to a standing order issued by a prescriber, (ii) in accordance with protocols developed by the Board of Pharmacy in consultation with the Board of Medicine and the Department of Health, and (iii) without charge or compensation. The bill also provides that dispensing may occur at a site other than that of the controlled substance registration, provided that the entity possessing the controlled substance registration maintains records in accordance with regulations of the Board of Pharmacy. The bill further provides that a person who dispenses naloxone shall not be liable for civil damages of ordinary negligence for acts or omissions resulting from the rendering of such treatment if he acts in good faith and that a person to whom naloxone has been dispensed pursuant to the provisions of the bill may possess naloxone and may administer naloxone to a person who is believed to be experiencing or about to experience a life-threatening opioid overdose. The bill contains an emergency clause. This bill is identical to us/states/va Virginia General Assembly 2017 HB 1453 Virginia HB 1453 (2017)
bill
Civil Remedies and Procedure
Commissions
Boards and Institutions Generally
Emergency Legislation
Narcotics and Drugs
Professions and Occupations
enacted
Dave A. LaRock
4 19 7 2016-12-02 2017-02-23 openstates ocd-bill/3b6cf8b2-ed3d-48e7-8f9c-226945138a9d http://lis.virginia.gov/cgi-bin/legp604.exe?171+sum+HB1453 48278e4dc13b139a3b983d19f582ea7cf3b3d558fe53bb6b6f050b21beceba92 2026-07-01 https://data.openstates.org/daily/2026-07-01/public.pgdump 2026-07-06 reported
legislation
bill
us-va

Virginia HB 1453 (2017) — Naloxone; dispensing for use in opioid overdose reversal, etc.

Allows a person who is authorized by the Department of Behavioral Health and Developmental Services to train individuals on the administration of naloxone for use in opioid overdose reversal and who is acting on behalf of an organization that provides services to individuals at risk of experiencing opioid overdose or training in the administration of naloxone for overdose reversal and that has obtained a controlled substances registration from the Board of Pharmacy pursuant to § 54.1-3423 to dispense naloxone to a person who has completed a training program on the administration of naloxone for opioid overdose reversal, provided that such dispensing is (i) pursuant to a standing order issued by a prescriber, (ii) in accordance with protocols developed by the Board of Pharmacy in consultation with the Board of Medicine and the Department of Health, and (iii) without charge or compensation. The bill also provides that dispensing may occur at a site other than that of the controlled substance registration, provided that the entity possessing the controlled substance registration maintains records in accordance with regulations of the Board of Pharmacy. The bill further provides that a person who dispenses naloxone shall not be liable for civil damages of ordinary negligence for acts or omissions resulting from the rendering of such treatment if he acts in good faith and that a person to whom naloxone has been dispensed pursuant to the provisions of the bill may possess naloxone and may administer naloxone to a person who is believed to be experiencing or about to experience a life-threatening opioid overdose. The bill contains an emergency clause. This bill is identical to

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

  1. Governor: Acts of Assembly Chapter text (CHAP0168) (committee substitute) — source
  2. House: Bill text as passed House and Senate (HB1453ER) (committee substitute) — source
  3. House: Committee substitute printed 17104396D-H1 (committee substitute) — source
  4. House: Prefiled and ordered printed; offered 01/11/17 17102196D (committee substitute) — source

Votes

  • Read third time and passed House BLOCK VOTE — 970 (pass) · legislature
  • Constitutional reading dispensed — 390 (pass) · legislature
  • Reported from Education and Health — 150 (pass) · legislature
  • Subcommittee recommends reporting with substitute — 110 (pass) · legislature
  • Rereferred from Courts of Justice — 150 (pass) · legislature
  • Reported from Health, Welfare and Institutions with substitute — 220 (pass) · legislature
  • Passed Senate — 400 (pass) · legislature

Sponsors

  • Dave A. LaRock — primary (person)
  • Amanda F. Chase — cosponsor (person)
  • Betsy B. Carr — cosponsor (person)
  • C. Matthew Fariss — cosponsor (person)
  • C.E. Cliff Hayes, Jr. — cosponsor (person)
  • Charniele L. Herring — cosponsor (person)
  • Christopher E. Collins — cosponsor (person)
  • Eileen Filler-Corn — cosponsor (person)
  • Gordon C. Helsel, Jr. — cosponsor (person)
  • J. Randall Minchew — cosponsor (person)
  • James M. LeMunyon — cosponsor (person)
  • Jennifer B. Boysko — cosponsor (person)
  • Jennifer L. McClellan — cosponsor (person)
  • Jill Holtzman Vogel — cosponsor (person)
  • John J. Bell — cosponsor (person)
  • John M. O'Bannon, III — cosponsor (person)
  • Joseph C. Lindsey — cosponsor (person)
  • Kathleen Murphy — cosponsor (person)
  • Kaye Kory — cosponsor (person)
  • Kenneth R. Plum — cosponsor (person)
  • L. Scott Lingamfelter — cosponsor (person)
  • Marcia S. "Cia" Price — cosponsor (person)
  • Mark L. Cole — cosponsor (person)
  • Michael J. Webert — cosponsor (person)
  • Michael P. Mullin — cosponsor (person)
  • Patrick A. Hope — cosponsor (person)
  • Paul E. Krizek — cosponsor (person)
  • Richard L. Anderson — cosponsor (person)
  • Richard P. Bell — cosponsor (person)
  • Robert B. Bell — cosponsor (person)
  • Robert D. Orrock, Sr. — cosponsor (person)
  • Robert G. Marshall — cosponsor (person)
  • Sam Rasoul — cosponsor (person)
  • Siobhan S. Dunnavant — cosponsor (person)
  • Steve E. Heretick — cosponsor (person)
  • Thomas A. "Tag" Greason — cosponsor (person)
  • Vivian E. Watts — cosponsor (person)

Timeline

The legislative action history — every referral, reading, and vote.

  • 2016-12-02 Prefiled and ordered printed; offered 01/11/17 17102196D introduction
  • 2016-12-02 Referred to Committee on Health, Welfare and Institutions referral-committee
  • 2017-01-12 Assigned HWI sub: Subcommittee #1 referral-committee
  • 2017-01-27 Read first time reading-1
  • 2017-01-30 Read second time reading-2
  • 2017-01-30 Committee substitute agreed to 17104396D-H1
  • 2017-01-30 Emergency clause added
  • 2017-01-30 Engrossed by House - committee substitute HB1453H1
  • 2017-01-31 Read third time and passed House BLOCK VOTE (97-Y 0-N) passage, reading-3
  • 2017-02-01 Constitutional reading dispensed
  • 2017-02-01 Referred to Committee for Courts of Justice referral-committee
  • 2017-02-06 Rereferred to Education and Health referral-committee
  • 2017-02-13 Read third time reading-3
  • 2017-02-15 Enrolled
  • 2017-02-15 Signed by Speaker
  • 2017-02-17 Signed by President
  • 2017-02-17 Enrolled Bill communicated to Governor on 2/17/17
  • 2017-02-17 Governor's Action Deadline Midnight, February 24, 2017
  • 2017-02-23 Approved by Governor-Chapter 168 (effective 2/23/17) executive-signature

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/3b6cf8b2-ed3d-48e7-8f9c-226945138a9d. Confidence: reported (aggregated from official Virginia legislature records).